Richmond, VANCT04054310Now EnrollingIRB Ready

NASH - Nonalcoholic Steatohepatitis Clinical Trial in Richmond, VA

Access cutting-edge nash - nonalcoholic steatohepatitis treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.

Sponsored by Perspectum

Quick Self-Assessment

See if you qualify for this Richmond location

Preparing your pre-screening questions…

Expert Care in Richmond

Access nash - nonalcoholic steatohepatitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nash - nonalcoholic steatohepatitis treatment provided free

Apply for This Richmond Location

Check if you qualify for this nash - nonalcoholic steatohepatitis clinical trial in Richmond, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Richmond

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Richmond site if eligible
  4. 4Begin participation

About This NASH - Nonalcoholic Steatohepatitis Study in Richmond

To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.

Sponsor: Perspectum

Who Can Participate

Inclusion Criteria

Male and Female subjects aged between 18 and 75 years old
Ability to understand and sign a written informed consent forms
Patients scheduled to undergo a standard of care diagnostic liver biopsy as follows
Percutaneous biopsy with a 16 gauged needle passed into the right lobe
Trans-jugular biopsy with an 18 gauged needle passed into the right lobe
Patients who are suspected of having NAFLD, who are being considered for treatment, and presenting with two or more of the following risk factors for NASH
Elevated liver enzymes (ALT≥40)
BMI≥25kG/m\^2
Hypertension
Type II diabetes
Dyslipidameia
Low High-density lipoprotein (HDL) (\<40mg/dl in men or \<50mg/dl in women)
Hypertriglyceridemia (≥150mg/dl)
Hypercholestrolemia (≥200mg/dl)
Triglycerides (TG)/HDL\>5.0

Exclusion Criteria

Prior histopathological diagnosis of NASH
Inability to undergo a liver biopsy
Prior or planned liver transplantation
Patient scheduled to undergo a laparoscopic or wedge liver biopsy or biopsy taken from the left lobe
Participation in an investigational new drug (IND) trial in the 30 days before enrolment
Other known causes of chronic liver disease based on clinical criteria at the study site such as the following:
Alcoholic liver disease
Primary biliary cirrhosis
Primary sclerosing cholangitis
Autoimmune Hepatitis
Wilson's disease, hemochromatosis, iron overload
Alpha/1/Antitrypsin (A1AT) deficiency
History or diagnosis of cirrhosis and or hepatic decompensation including ascites, hepatic encephalopathy or variceal bleeding
Clinically relevant drug or alcohol abuse within 12 months of screening
Any contradiction or significant limitation to MRI scanning
Claustrophobia preventing MR imaging (requires 15-30 minutes in scanning)
Pacemaker or another implanted device
Metal in body (such as an aneurysm clip) that might produce artefacts on abdominal MRI or might be adversely impacted by a high magnetic field
Inability to lie flat, remain still or briefly hold breath as necessary during MR imaging
Medical condition likely to produce significant hypervolemia like congestive heart failure
Severe obesity complicating positioning in MR scanner
Weight reduction surgery within 3 years
Concomitant medical illnesses per investigators discretion (such as HIV infection, recent major surgery, uncontrolled heart disease, concurrent infection or fever of unknown origin, illicit drug use, cancer
Clinically significant medical or psychiatric condition considered a high risk participation in an investigational study
Failure to give informed consent

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Richmond?

Yes, this clinical trial (NCT04054310) has an active research site in Richmond, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

NASH - Nonalcoholic Steatohepatitis Treatment Options in Richmond, VA

If you're searching for nash - nonalcoholic steatohepatitis treatment options in Richmond, VA, this clinical trial (NCT04054310) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nash - nonalcoholic steatohepatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nash - nonalcoholic steatohepatitis clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Richmond, VA

See all ankylosing spondylitis clinical trials recruiting in Richmond — not just this study.

Browse Ankylosing Spondylitis Trials in Richmond →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsNASH TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Richmond?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Richmond, VA